An Indonesian Pregnant Woman with Systemic Lupus Erythematosus and Cardiac Tamponade: A Case Report

May 2022 in “ International Journal of Surgery Case Reports ”

Resa Felani, Awalia

systemic lupus erythematosus SLE hair loss immunosuppressants cyclophosphamide

TLDR Pericardiocentesis and immunosuppressants effectively treat cardiac tamponade in pregnant women with SLE.

This case report details a 33-year-old pregnant Indonesian woman with systemic lupus erythematosus (SLE) who developed cardiac tamponade, presenting with symptoms such as shortness of breath, swollen legs, hair loss, and joint pain. She was initially treated with ultrasound-guided pericardiocentesis and methylprednisolone, leading to temporary improvement. However, she experienced a recurrence of cardiac tamponade but declined further hospital treatment. The report underscores the prevalence of cardiac tamponade during SLE flares in pregnancy and the critical role of pericardiocentesis and immunosuppressant therapy in its management.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

research Flares of Systemic Lupus Erythematosus During Pregnancy and the Puerperium: Prevention, Diagnosis, and Management

87 citations, July 2012 in “Expert Review of Clinical Immunology”

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Related Community Posts Join

6 / 1000+ results

community Hair Remedies that Don't Work for Anybody Seeking Hair Regrowth

in Treatment 6 upvotes 4 years ago

Hair loss treatments discussed include minoxidil, finasteride, and RU58841. Salon products and supplements generally don't work for hair regrowth unless there's a severe nutritional deficiency, while hormonal treatments like estrogen and spironolactone can be effective.

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 4 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community 2024 guide for male pattern baldness: 10 take home messages from Dr. Moreno-Arrones

in Research/Science 244 upvotes 2 months ago

Effective treatments for male pattern baldness include finasteride, dutasteride, and oral minoxidil. Non-effective approaches include oils, shampoos, serums, laser therapies, massages, vitamins, and microneedling.

community Minoxidil Finasteride heart problems

in Update 97 upvotes 7 months ago

A user experienced heart problems after taking 1mg finasteride and 2.5mg oral minoxidil and is considering quitting minoxidil. Others discussed their experiences with heart issues and minoxidil, with some suggesting topical minoxidil as a safer alternative.

community Seeking Advice: Unusual Hair Loss at 31 Years Old - Any Insights? (M)

in Chat 15 upvotes 8 months ago

A 31-year-old man who previously had good results with minoxidil, finasteride, and nizoral for hair loss is now experiencing unusual hair loss and side effects from finasteride. Respondents suggest it might be severe retrograde alopecia and recommend exploring other treatment options due to his inability to tolerate finasteride.

community A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review

in Research/Science 6 upvotes 6 months ago

Topical formulations, natural products, and CAM therapies are being used to treat Androgenic alopecia to avoid side effects of Finasteride and Minoxidil. The review covers various low-risk, alternative treatment options.

Similar Research

5 / 1000+ results

research Clinical Features of Systemic Lupus Erythematosus Patients Complicated with Evans Syndrome

15 citations, April 2016 in “Medicine”

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

Chinese SLE Treatment and Research Group Registry XIII: Prevalence and Risk Factors for Chronic Scarring Alopecia in Patients with Systemic Lupus Erythematosus

research Chinese SLE Treatment and Research Group Registry XIII: Prevalence and Risk Factors for Chronic Scarring Alopecia in Patients with Systemic Lupus Erythematosus

1 citations, January 2021 in “Arthritis Research & Therapy”

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.